Post-transplant lymphoproliferative disease Advocacy Hub | UniteRare

At a Glance

Live from database

🔬

12Recruiting trials

🩺

67Specialists

Regulatory Watchboard

10 events

Nov 2026EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases

University Hospital, Basel, Switzerland — PHASE1, PHASE2

TrialNOT YET RECRUITING

Jul 2025Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma

Northwestern University — PHASE2

TrialACTIVE NOT RECRUITING

Jul 2025Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients

Intergroupe Francophone du Myelome — PHASE3

TrialRECRUITING

Jun 2025Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation

Daihong Liu — PHASE1, PHASE2

TrialRECRUITING

Apr 2025Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

Jennifer Amengual — PHASE2

TrialRECRUITING

Mar 2025EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell Transplantation

Daihong Liu — PHASE1, PHASE2

TrialRECRUITING

Mar 2025Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCT

First Affiliated Hospital of Zhejiang University — PHASE2

TrialNOT YET RECRUITING

Mar 2025KPD Consolidation After ASCT in NDMM Patients

Peking University People's Hospital — PHASE2, PHASE3

TrialRECRUITING

Oct 2024PTLD: Multicentric Retrospective Study

Fondazione Italiana Linfomi - ETS

TrialACTIVE NOT RECRUITING

Jul 2024Phase II Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia

Institute of Hematology & Blood Diseases Hospital, China — PHASE2

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Post-transplant lymphoproliferative disease.
Check the disease page for updates →

Clinical Trial Landscape

12 active trials

1Phase 4

4Phase 2

1Phase 1

1N/A

1Unknown

3PHASE1, PHASE2

1EARLY_PHASE1

12Total recruiting

Search clinical trials for Post-transplant lymphoproliferative disease →

Recent News & Research

No recent news articles indexed yet for Post-transplant lymphoproliferative disease.
Search PubMed for Post-transplant lymphoproliferative disease →

Browse all Post-transplant lymphoproliferative disease news →

Specialist Network

Top 6 by expertise

Aurore PERROT, Prof

IUCT Toulouse France

Score 411 trial

Cyrille TOUZEAU, Prof

CHU Nantes France

Score 411 trial

Kurt Gunter, MD, M.D

Inozyme Pharma, Inc.

📍 BEVERLY, MA

Score 288 trials

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Score 2111 trials

Corey Cutler, MD, MPH, F.N.P

Dana-Farber Cancer Institute

📍 PARK CITY, UT

Score 213 trials

Chanaz LOUNI

The Institute for Functional Medicine

Score 181 trial

View all Post-transplant lymphoproliferative disease specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰